Skip to content

STVN

Stevanato Group S.p.A.

NYSE · ITHealthcareMedical - Instruments & Supplies
$19.15-0.10%

Price as of Jul 20, 2026

STVN growth

Stevanato Group S.p.A. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+6.7%
EBITDA
-1.5%
EBIT
+16.6%
EPS
+9.5%
Free cash flow
+95.9%
Operating cash flow
-6.4%

Forward estimates

Revenue
+31.4%
EBITDA
+33.0%
EPS
+63.0%

Three-year CAGR

Revenue
+5.0%
EBITDA
+4.0%
EBIT
-1.6%
Net income
-2.0%
EPS
-2.6%
Free cash flow
+113.6%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.